| Title: |
New antiviral agents. |
| Authors: |
Abdel-Haq N; Chearskul P; Al-Tatari H; Asmar B; Abdel-Haq, Nahed; Chearskul, Pimpanada; Al-Tatari, Hossam; Asmar, Basim |
| Source: |
Indian Journal of Pediatrics; Apr2006, Vol. 73 Issue 4, p313-321, 9p |
| Abstract: |
During the last three decades, a better understanding of viral replication and disease states caused by viral infections have led to the development of newer antiviral agents with enhanced activity and better tolerability. This review focuses on newer systemic and topical antiviral agents that are used in treatment of herpes viruses including herpes simplex type-1 (HSV-1) and type-2 (HSV-2), varicella-zoster virus (VZV) and cytomegalovirus CMV) as well as the human papilloma virus (HPV). Included in this article are the agents famciclovir, penciclovir, valganciclovir, imiquimod, docosanole and brivudin. [ABSTRACT FROM AUTHOR] |
| : |
Copyright of Indian Journal of Pediatrics is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |